Manchester Capital Management LLC Acquires Shares of 882 Genpact Limited (NYSE:G)

Manchester Capital Management LLC acquired a new stake in Genpact Limited (NYSE:G) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 882 shares of the business services provider’s stock, valued at approximately $38,000.

A number of other institutional investors also recently bought and sold shares of G. Sanctuary Advisors LLC acquired a new position in shares of Genpact during the second quarter worth about $335,000. Creative Planning increased its stake in shares of Genpact by 19.4% during the third quarter. Creative Planning now owns 30,590 shares of the business services provider’s stock worth $1,199,000 after acquiring an additional 4,976 shares during the period. Aaron Wealth Advisors LLC acquired a new position in shares of Genpact during the third quarter worth about $270,000. Vest Financial LLC increased its stake in shares of Genpact by 12.9% during the third quarter. Vest Financial LLC now owns 39,012 shares of the business services provider’s stock worth $1,530,000 after acquiring an additional 4,458 shares during the period. Finally, Suncoast Equity Management increased its stake in shares of Genpact by 3.1% during the third quarter. Suncoast Equity Management now owns 12,600 shares of the business services provider’s stock worth $494,000 after acquiring an additional 375 shares during the period. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Genpact

In related news, SVP Piyush Mehta sold 12,000 shares of the company’s stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Balkrishan Kalra sold 13,600 shares of the company’s stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the transaction, the chief executive officer now directly owns 267,404 shares of the company’s stock, valued at $11,926,218.40. This trade represents a 4.84 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 35,058 shares of company stock valued at $1,558,675. Company insiders own 2.80% of the company’s stock.

Genpact Stock Down 0.9 %

Shares of NYSE G opened at $55.06 on Friday. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $56.76. The company has a market capitalization of $9.71 billion, a PE ratio of 19.39, a price-to-earnings-growth ratio of 1.63 and a beta of 1.20. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85. The firm’s 50-day moving average is $46.03 and its two-hundred day moving average is $42.08.

Genpact (NYSE:G) last announced its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.61%. Equities analysts anticipate that Genpact Limited will post 3.08 EPS for the current fiscal year.

Genpact Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be paid a dividend of $0.17 per share. This is an increase from Genpact’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Tuesday, March 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.24%. Genpact’s dividend payout ratio is presently 21.48%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on G shares. TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and boosted their price target for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Robert W. Baird boosted their price objective on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Jefferies Financial Group raised shares of Genpact from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Needham & Company LLC boosted their price objective on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Finally, Mizuho boosted their price objective on shares of Genpact from $45.00 to $55.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Six investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, Genpact has a consensus rating of “Hold” and an average price target of $48.44.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.